Author:
Chance Randy,Kang Angray Singh
Abstract
Monoclonal antibody biologics have significantly transformed the therapeutic landscape within the biopharmaceutical industry, partly due to the utilisation of discovery technologies such as the hybridoma method and phage display. While these established platforms have streamlined the development process to date, their reliance on cell transformation for antibody identification faces limitations related to library diversification and the constraints of host cell physiology. Cell-free systems like ribosome display offer a complementary approach, enabling antibody selection in a completely in vitro setting while harnessing enriched cellular molecular machinery. This review aims to provide an overview of the fundamental principles underlying the ribosome display method and its potential for advancing antibody discovery and development.
Reference123 articles.
1. Cell-free systems: functional modules for synthetic and chemical biology, (in eng);Stech;Adv Biochem Eng Biotechnol.,2013
2. In vitro selection and affinity maturation of antibodies from a naive combinatorial immunoglobulin library, (in eng);Gram;Proc Natl Acad Sci U S A,1992
3. Decorating microbes: surface display of proteins on Escherichia coli, (in eng);van Bloois;Trends Biotechnol,2011
4. Yeast surface display for screening combinatorial polypeptide libraries, (in eng);Boder;Nat Biotechnol,1997
5. Isolation of human monoclonal antibodies by mammalian cell display, (in eng);Beerli;Proc Natl Acad Sci U S A,2008